Skip to main content

Table 2 Medications at baseline and six months

From: Placebo-controlled randomized clinical trial of fish oil’s impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus

 

Placebo (N=14)

Fish oil (N=18)

 

Baseline

Six months

Baseline

Six months

Prednisone

    

 0 mg/day

5 (36 %)

7 (50 %)

7 (39 %)

5 (28 %)

 ≤7.5 mg/day

5 (36 %)

4 (29 %)

2 (11 %)

1 (6 %)

 >7.5 mg/day

4 (29 %)

3 (21 %)

9 (50 %)

12 (67 %)

 Median [IQR] mg/day

5 [0–20]

3 [0–9]

8 [0–20]

10 [0–15]

Hydroxychloroquine

12 (86 %)

14 (100 %)

16 (89 %)

16 (89 %)

Other Immunosuppressants

    

 Cyclophosphamide

0 (0 %)

1 (7 %)

1 (5 %)

1 (5 %)

 Mycophenolate

8 (57 %)

7 (50 %)

7 (39 %)

10 (56 %)

 Azathioprine

2 (14 %)

2 (14 %)

0 (0 %)

0 (0 %)

Misc. Medications

    

 Statin

2 (14 %)

2 (14 %)

7 (39 %)

10 (56 %)

 ACE/ARB

9 (64 %)

9 (64 %)

12 (67 %)

14 (78 %)

  1. Background medications for all completers at baseline and study completion. Data presented as number of patients (%) or median and interquartile range [IQR]